Cargando…

Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists

2′,3′‐cGAMP is a cyclic A‐ and G‐containing dinucleotide second messenger, which is formed upon cellular recognition of foreign cytosolic DNA as part of the innate immune response. The molecule binds to the adaptor protein STING, which induces an immune response characterized by the production of ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Stazzoni, Samuele, Böhmer, Daniel F. R., Hernichel, Fabian, Özdemir, Dilara, Pappa, Aikaterini, Drexler, David, Bauernfried, Stefan, Witte, Gregor, Wagner, Mirko, Veth, Simon, Hopfner, Karl‐Peter, Hornung, Veit, König, Lars M., Carell, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804856/
https://www.ncbi.nlm.nih.gov/pubmed/35876840
http://dx.doi.org/10.1002/anie.202207175
_version_ 1784862208277086208
author Stazzoni, Samuele
Böhmer, Daniel F. R.
Hernichel, Fabian
Özdemir, Dilara
Pappa, Aikaterini
Drexler, David
Bauernfried, Stefan
Witte, Gregor
Wagner, Mirko
Veth, Simon
Hopfner, Karl‐Peter
Hornung, Veit
König, Lars M.
Carell, Thomas
author_facet Stazzoni, Samuele
Böhmer, Daniel F. R.
Hernichel, Fabian
Özdemir, Dilara
Pappa, Aikaterini
Drexler, David
Bauernfried, Stefan
Witte, Gregor
Wagner, Mirko
Veth, Simon
Hopfner, Karl‐Peter
Hornung, Veit
König, Lars M.
Carell, Thomas
author_sort Stazzoni, Samuele
collection PubMed
description 2′,3′‐cGAMP is a cyclic A‐ and G‐containing dinucleotide second messenger, which is formed upon cellular recognition of foreign cytosolic DNA as part of the innate immune response. The molecule binds to the adaptor protein STING, which induces an immune response characterized by the production of type I interferons and cytokines. The development of STING‐binding molecules with both agonistic as well as antagonistic properties is currently of tremendous interest to induce or enhance antitumor or antiviral immunity on the one hand, or to treat autoimmune diseases on the other hand. To escape the host innate immune recognition, some viruses encode poxin endonucleases that cleave 2′,3′‐cGAMP. Here we report that dideoxy‐2′,3′‐cGAMP (1) and analogs thereof, which lack the secondary ribose‐OH groups, form a group of poxin‐stable STING agonists. Despite their reduced affinity to STING, particularly the compound constructed from two A nucleosides, dideoxy‐2′,3′‐cAAMP (2), features an unusually high antitumor response in mice.
format Online
Article
Text
id pubmed-9804856
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98048562023-01-06 Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists Stazzoni, Samuele Böhmer, Daniel F. R. Hernichel, Fabian Özdemir, Dilara Pappa, Aikaterini Drexler, David Bauernfried, Stefan Witte, Gregor Wagner, Mirko Veth, Simon Hopfner, Karl‐Peter Hornung, Veit König, Lars M. Carell, Thomas Angew Chem Int Ed Engl Communications 2′,3′‐cGAMP is a cyclic A‐ and G‐containing dinucleotide second messenger, which is formed upon cellular recognition of foreign cytosolic DNA as part of the innate immune response. The molecule binds to the adaptor protein STING, which induces an immune response characterized by the production of type I interferons and cytokines. The development of STING‐binding molecules with both agonistic as well as antagonistic properties is currently of tremendous interest to induce or enhance antitumor or antiviral immunity on the one hand, or to treat autoimmune diseases on the other hand. To escape the host innate immune recognition, some viruses encode poxin endonucleases that cleave 2′,3′‐cGAMP. Here we report that dideoxy‐2′,3′‐cGAMP (1) and analogs thereof, which lack the secondary ribose‐OH groups, form a group of poxin‐stable STING agonists. Despite their reduced affinity to STING, particularly the compound constructed from two A nucleosides, dideoxy‐2′,3′‐cAAMP (2), features an unusually high antitumor response in mice. John Wiley and Sons Inc. 2022-08-31 2022-10-04 /pmc/articles/PMC9804856/ /pubmed/35876840 http://dx.doi.org/10.1002/anie.202207175 Text en © 2022 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Communications
Stazzoni, Samuele
Böhmer, Daniel F. R.
Hernichel, Fabian
Özdemir, Dilara
Pappa, Aikaterini
Drexler, David
Bauernfried, Stefan
Witte, Gregor
Wagner, Mirko
Veth, Simon
Hopfner, Karl‐Peter
Hornung, Veit
König, Lars M.
Carell, Thomas
Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
title Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
title_full Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
title_fullStr Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
title_full_unstemmed Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
title_short Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
title_sort novel poxin stable cgamp‐derivatives are remarkable sting agonists
topic Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804856/
https://www.ncbi.nlm.nih.gov/pubmed/35876840
http://dx.doi.org/10.1002/anie.202207175
work_keys_str_mv AT stazzonisamuele novelpoxinstablecgampderivativesareremarkablestingagonists
AT bohmerdanielfr novelpoxinstablecgampderivativesareremarkablestingagonists
AT hernichelfabian novelpoxinstablecgampderivativesareremarkablestingagonists
AT ozdemirdilara novelpoxinstablecgampderivativesareremarkablestingagonists
AT pappaaikaterini novelpoxinstablecgampderivativesareremarkablestingagonists
AT drexlerdavid novelpoxinstablecgampderivativesareremarkablestingagonists
AT bauernfriedstefan novelpoxinstablecgampderivativesareremarkablestingagonists
AT wittegregor novelpoxinstablecgampderivativesareremarkablestingagonists
AT wagnermirko novelpoxinstablecgampderivativesareremarkablestingagonists
AT vethsimon novelpoxinstablecgampderivativesareremarkablestingagonists
AT hopfnerkarlpeter novelpoxinstablecgampderivativesareremarkablestingagonists
AT hornungveit novelpoxinstablecgampderivativesareremarkablestingagonists
AT koniglarsm novelpoxinstablecgampderivativesareremarkablestingagonists
AT carellthomas novelpoxinstablecgampderivativesareremarkablestingagonists